Page results
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.
-
Mr Attilakos is a consultant in fetal medicine and obstetrics who specialises in looking after complicated and uncomplicated multiple pregnancies.
-
This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain and spine. This treatment may also be referred to as whole central nervous system (CNS) or cranio-spinal radiotherapy.
-
This page has been written for parents and carers whose child is having total body irradiation (TBI) for leukaemia, lymphoma, or some other rare blood disorder.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the spine (backbone).
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
File results
-
FOI/2021/0588 - Pregnant unvaccinated women in ICU with Covid-19
-
FOI/2021/0591 - Laboratory/ Pathology information system
-
FOI/2021/0592 - Medical device integration
-
FOI/2021/0594 - Authorisation of mechanical restraint
-
FOI/2021/0596 - Expenditure on translation services
-
FOI/2021/0597 - Bariatric beds/ equipment costs
-
FOI/2021/0598 - Pregnant theatre staff in operating rooms departmental guidelines
-
FOI/2021/0599 - Treating patients with Dravet syndrome
-
FOI/2021/0600 - Rota and rostering supplier information
-
FOI/2021/0601 - Treatment Guidelines with Systemic lupus erythematosus (SLE) / Lupus nephritis (LN)